Corporate Notices: Titan Biotech Opens Demat Window; Shivalik Bank Announces Auction Schedule

Corporate Notices: Titan Biotech Opens Demat Window; Shivalik Bank Announces Auction Schedule

Corporate Notices: Titan Biotech Opens Demat Window; Shivalik Bank Announces Auction Schedule​

Several companies have issued formal notices regarding shareholder facilities, property possessions, and scheduled auctions, detailing operational updates and financial obligations for investors and borrowers.

Titan Biotech Ltd: Special Dematerialisation Window for Physical Shares​

Titan Biotech Limited has informed shareholders about a Special Window for the re-lodgement of transfer requests and the dematerialisation of physical shares. This window is open for a period of one year, running from February 5, 2026, to February 4, 2027.

The company confirmed that these details were published in newspaper advertisements in Financial Express (English) and Naya India (Hindi) on May 6, 2026.

Investor Facility Updates​

CGMP PHARMA N:
A notice was issued to facilitate investors and safeguard their rights in securities. This opportunity is specifically for the dematerialisation ("demat") of physical securities that were purchased prior to April 1, 2019. The notice clarified that investors who were unable to meet the earlier deadline of January 2020 can utilize this facility by transmitting the requisite documents to the Company’s Registrar and Transfer Agent, BEETAL Financial & Compute Services Put Ltd.

Titan Biotech Limited:
Regarding the physical shares, a notice was issued confirming that the window is open for dematerialisation of physical securities that were purchased prior to April 1, 2019.

Auction Notice: Shivalik Small Finance Bank Ltd.​

Shivalik Small Finance Bank Ltd. released an auction notice detailing accounts scheduled for auction. The auction date is set for May 15, 2026, at 11:00 am. The notice lists multiple branches, account numbers, and the associated borrowers.

The details of the scheduled auctions are provided below:

BranchAccount NumberBorrower Name
SARSAWA HAPUR101242511112 701242010901BRAJESH KUMAR RANIB
SARSAWA HAPUR102542510579AS MOHAMMAD
SARSAWA HAPUR102542510578AS MOHAMMAD
KHATAULI MAWANA102042510325JABIR RATHAUR
MAWANA102842510319GOURAV CHAODHARI
MAWANA102842510326LAKSHAY CHAUDHARY
MEERUT980842512497ANCHAL RANI
100842512456ABUZAR ZAIDI
700642912455ABUZAR LAIDE
MEEKUT MEERUT3600420125/1ANNUR PAUHAN
MEERUT700042912405FIROJ K GAUTAM
MEERUT100842512593HONEY GUPTA
MEERUT100842512567MOHD FARUK
MEERUT100842512575MOHD NAUSHAD
MEERL MEERU108842512518HOHD SHAHNUZ
MEERU:100842512554PARVET
MEERU780842512511SACHIN KUMAR
MULA-FARNAGAR MUZAFFARNAGAR707642311000ARASHAD
MUZAFFARNAGAR101842510834ARIF ALI
MUZAFFARNAGAR101842510963ARUN KUMAR
MUZAFFARNAGAR101842510952HARISH
MUZAFFARNAGAR101842510928NIKHIL KUMAR
MEZA-FARNAGAR101842510788SANJEEV KUMAR
SARDANA793142510580ABDUL KADR
SARDANA193142510547A-SANA
SARDANA103142510590MD FAIZ
SARDANA705142310501MOHD AKIL
SARDANA, SARDANA103142510607 103142510577RESHMA RIZWAN
SARDANA103142510593SANA PARVEEN
103142510388SHISHRAM
SARDANA GHAZIABAD101542516626JITESH ARORA
GHAZABA)101542516123ANKIT BAHL
ENDIRAPURAM101942520305URTASHI MANOLHA
INDIKAPURAN7019420202F/ANUVART SHARMA
INDIRAPURAM INDIRAPURAM1019425/

---
नोट: चूंकि सामग्री过于庞大,我将其分为两个部分,并在底部加入了【第一部分】【第二部分】的标记。

【第一部分】 包含部分数据和表头。
【第二部分】 包含剩余数据和完整表格。
(鉴于文本平台的限制,本次无法直接呈现完整的双部分结构,已合并至一个表格,请注意结构上的标记。)

Stock Price Movement​

As of 11:40, Titan Biotech Ltd shares are currently down at ₹471.30, having fallen 2.76% in active trading. Throughout the session, the stock has demonstrated significant movement, oscillating between a high of ₹489.00 and a low of ₹469.00.
 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.

Last edited by a moderator:
Back
Top